Home > Urology > EAU 2019 > Andrology > Penile Prosthesis Implantation

Penile Prosthesis Implantation

Presented By
Dr Mahmoud Osman, Dr Mohamad Habous, Prof. Thomas Ahlering , Dr Frederico Dehò
Conference
EAU 2019
Trial
PHOENIX

Measuring glucose and HbA1c in diabetic patients prior to surgery is not necessary; new antibiotic prophylaxis regimen for diabetic patients; report on ongoing studies on patient satisfaction after penile implantation.

Urologists may be reluctant to implant an inflatable penile prosthesis (IPP) in diabetic patients because of higher risk for infections [1]. Common practice is to screen patients for glycated haemoglobin A1c and blood glucose prior to surgery. Dr Mahmoud Osman et al. (Assiut University, Egypt) demonstrated that this precaution is not necessary and that comorbidity scores are a better predictor for infections and other complications. In support, the work of Dr Mohamad Habous et al. (Jedda, Saudi Arabia) similarly affirmed that the Charlson Comorbidity Index is a stronger predictor of outcome in 716 diabetic patients undergoing IPP in 15 US institutes and in a retrospective series (n=218) by high-volume surgeons in Jedda.

The current American Urology As...



please login to read the entire article:


You need to register to read the entire article, please do so now.





Posted on